» Articles » PMID: 34853818

3D Bioprinting for Orthopaedic Applications: Current Advances, Challenges and Regulatory Considerations

Overview
Journal Bioprinting
Date 2021 Dec 2
PMID 34853818
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In the era of personalised medicine, novel therapeutic approaches raise increasing hopes to address currently unmet medical needs by developing patient-customised treatments. Three-dimensional (3D) bioprinting is rapidly evolving and has the potential to obtain personalised tissue constructs and overcome some limitations of standard tissue engineering approaches. Bioprinting could support a wide range of biomedical applications, such as drug testing, tissue repair or organ transplantation. There is a growing interest for 3D bioprinting in the orthopaedic field, with remarkable scientific and technical advances. However, the full exploitation of 3D bioprinting in medical applications still requires efforts to anticipate the upcoming challenges in translating bioprinted products from bench to bedside. In this review we summarised current trends, advances and challenges in the application of 3D bioprinting for bone and cartilage tissue engineering. Moreover, we provided a detailed analysis of the applicable regulations through the 3D bioprinting process and an overview of available standards covering bioprinting and additive manufacturing.

Citing Articles

Three-Dimensional Printing/Bioprinting and Cellular Therapies for Regenerative Medicine: Current Advances.

Sousa A, Alvites R, Lopes B, Sousa P, Moreira A, Coelho A J Funct Biomater. 2025; 16(1).

PMID: 39852584 PMC: 11765675. DOI: 10.3390/jfb16010028.


Bioprinting and Intellectual Property: Challenges, Opportunities, and the Road Ahead.

Kantaros A, Ganetsos T, Petrescu F, Alysandratou E Bioengineering (Basel). 2025; 12(1).

PMID: 39851350 PMC: 11761581. DOI: 10.3390/bioengineering12010076.


Current advances in the development of microRNA-integrated tissue engineering strategies: a cornerstone of regenerative medicine.

Castanon-Cortes L, Bravo-Vazquez L, Santoyo-Valencia G, Medina-Feria S, Sahare P, Duttaroy A Front Bioeng Biotechnol. 2024; 12:1484151.

PMID: 39479296 PMC: 11521876. DOI: 10.3389/fbioe.2024.1484151.


Three-Dimensional Bioprinting: A Comprehensive Review for Applications in Tissue Engineering and Regenerative Medicine.

Mirsky N, Ehlen Q, Greenfield J, Antonietti M, Slavin B, Nayak V Bioengineering (Basel). 2024; 11(8).

PMID: 39199735 PMC: 11351251. DOI: 10.3390/bioengineering11080777.


Strategies in product engineering of mesenchymal stem cell-derived exosomes: unveiling the mechanisms underpinning the promotive effects of mesenchymal stem cell-derived exosomes.

Jiang Y, Lv H, Shen F, Fan L, Zhang H, Huang Y Front Bioeng Biotechnol. 2024; 12:1363780.

PMID: 38756412 PMC: 11096451. DOI: 10.3389/fbioe.2024.1363780.


References
1.
Fedorovich N, Wijnberg H, Dhert W, Alblas J . Distinct tissue formation by heterogeneous printing of osteo- and endothelial progenitor cells. Tissue Eng Part A. 2011; 17(15-16):2113-21. DOI: 10.1089/ten.TEA.2011.0019. View

2.
Kang H, Lee S, Ko I, Kengla C, Yoo J, Atala A . A 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat Biotechnol. 2016; 34(3):312-9. DOI: 10.1038/nbt.3413. View

3.
Keriquel V, Oliveira H, Remy M, Ziane S, Delmond S, Rousseau B . In situ printing of mesenchymal stromal cells, by laser-assisted bioprinting, for in vivo bone regeneration applications. Sci Rep. 2017; 7(1):1778. PMC: 5431768. DOI: 10.1038/s41598-017-01914-x. View

4.
Aljohani W, Ullah M, Zhang X, Yang G . Bioprinting and its applications in tissue engineering and regenerative medicine. Int J Biol Macromol. 2017; 107(Pt A):261-275. DOI: 10.1016/j.ijbiomac.2017.08.171. View

5.
Daly A, Kelly D . Biofabrication of spatially organised tissues by directing the growth of cellular spheroids within 3D printed polymeric microchambers. Biomaterials. 2019; 197:194-206. DOI: 10.1016/j.biomaterials.2018.12.028. View